DUPONT CAPITAL MANAGEMENT CORP - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 110 filers reported holding TG THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
DUPONT CAPITAL MANAGEMENT CORP ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$223,457
+80.2%
18,889
-9.7%
0.01%
+57.1%
Q3 2022$124,000
-80.1%
20,914
-55.9%
0.01%
-53.3%
Q2 2018$624,000
-24.8%
47,454
-18.8%
0.02%
-25.0%
Q1 2018$830,000
+55.7%
58,421
-10.1%
0.02%
+66.7%
Q4 2017$533,000
+75.3%
64,957
+153.1%
0.01%
+71.4%
Q3 2017$304,000
+17.8%
25,6620.0%0.01%
+16.7%
Q2 2017$258,00025,6620.01%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
M28 Capital Management LP 726,200$3,086,0003.46%
Paradigm Biocapital Advisors LP 1,964,709$8,350,0001.66%
683 Capital Management, LLC 3,300,000$14,025,0000.99%
MAVERICK CAPITAL LTD 6,747,549$28,677,0000.71%
Antara Capital LP 1,500,000$6,375,0000.27%
Parkwood LLC 47,168$1,375,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,677,500$11,379,0000.24%
PURA VIDA INVESTMENTS, LLC 950,813$4,041,0000.24%
OCCUDO QUANTITATIVE STRATEGIES LP 567,576$2,412,0000.20%
Antara Capital LP 900,000$3,825,0000.16%
View complete list of TG THERAPEUTICS INC shareholders